◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Bangkok Dusit Medical Services Public Company Limited (BDMS) Net Income 2021–2025

Name: Bangkok Dusit Medical Services Public Company Limited (BDMS) net income history 2021-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Bangkok Dusit Medical Services Public Company Limited annual net income for fiscal 2025 was THB 15.8 billion, a decrease of 0.9% from THB 16.0 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

BDMS Annual Net Income

Net Income (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Net Income	THB 15.8B	THB 16.0B	THB 14.4B	THB 12.6B	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BDMS Quarterly Net Income

Net Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Net Income	THB 3.2B	THB 4.1B	THB 3.7B	THB 4.3B	THB 3.5B	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

ASTERDM Net Income — Aster DM Quality Care Limited
MEDANTA Net Income — Global Health Limited
NH Net Income — Narayana Hrudayalaya Limited
KIMS Net Income — Krishna Institute of Medical Sciences Limited

More BDMS metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow

All BDMS financial statements → Interactive BDMS charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.